19:10 - 21:00
Room: Ishikawa Ongakudō Interchange Hall
Poster Session
TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and metastasis
Xing Qin1, Ming Yan1, Jianjun Zhang1, Wantao Chen1, 2
1Department of Oral and Maxillofacial-Head & Neck Oncology and Faculty of Oral and Maxillofacial Surgery, Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine,639, Zhizaoju Road, Shanghai 200011, China, Shanghai, China, China, 2Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai, 200011, PR China., Shanghai, China, China

TGFβ3, a multifunctional cytokine, was reported as a direct critical driver of tumor growth and metastasis in numerous cancers. Cancer-associated fibroblasts (CAFs), as the activated fibroblasts in tumor stroma, are important modifiers of tumor progression. However, the molecular mechanisms underlying the tumor-promoting properties of TGFβ3 and CAFs in head and neck cancer (HNC) remain unclear. Here, we show that CAFs isolated from HNC produce significant amounts of TGFβ3 and IL-6. CAFs enhances the growth and metastasis of HNC cells through the secretion of TGFβ3that induces the expression of periostin (POSTN) in HNC cells. Our results indicated that POSTN was significantly up-regulated in HNCs, especially in the tissues with lymph node metastasis. Moreover, POSTN was highly enriched in the stroma of cancer tissues and produced mainly by CAFs. More importantly, we have pinpointed TGF-β3 as the major upstream molecular that triggers the induction of POSTN in CAFs. As such, during the interaction between fibroblasts and cancer cells, the increased stromal POSTN induced by TGF-β3 directly accelerated the growth, migration and invasion of cancer cells. Hence, our study has provided a novel modulative role for POSTN on HNC progression and further reveals POSTN as an effective biomarker to predict metastasis as well as a potential cancer therapeutic target. This work was supported by the National Program on Key Research Project of China (2016YFC0902700) and the National Natural Science Foundation of China (81472572 and 91229103).


Reference:
Tu-P14-38
Session:
Poster Session 14 “Cytokines in cancer development and antitumor immune therapy”
Presenter/s:
Wantao Chen
Presentation type:
Poster Presentation
Room:
Ishikawa Ongakudō Interchange Hall
Date:
Tuesday, 31 October 2017
Time:
19:10 - 21:00
Session times:
19:10 - 21:00